{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T22:16:24Z","timestamp":1786659384562,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jns.2016.09.061","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T08:24:09Z","timestamp":1475828649000},"page":"36-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Polyneuropathy in levodopa-treated Parkinson's patients"],"prefix":"10.1016","volume":"371","author":[{"given":"Karol","family":"Szadejko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Dziewiatowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Szabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Robowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Schinwelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Sitek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"S\u0142awek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2016.09.061_bb0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med."},{"key":"10.1016\/j.jns.2016.09.061_bb0010","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/mds.10629","article-title":"Hyperhomocysteinaemia in treated patients with Huntington's disease","volume":"19","author":"Andrich","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.09.061_bb0015","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/mds.21500","article-title":"Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome","volume":"22","author":"Antonini","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.09.061_bb0020","first-page":"272","article-title":"Genetic and environmental factors for hyperhomocysteinaemia and its clinical implications in Parkinson's disease","volume":"43","author":"Bia\u0142ecka","year":"2009","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.jns.2016.09.061_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0021-9150(95)05730-7","article-title":"Homocysteine mediatel endothelial cell toxicity and its amelioration","volume":"122","author":"Blundell","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jns.2016.09.061_bb0030","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.2337\/diacare.25.11.2048","article-title":"Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy","volume":"11","author":"Bril","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2016.09.061_bb0035","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.25585","article-title":"Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study","volume":"10","author":"Ceravolo","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.09.061_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.parkreldis.2016.01.026","article-title":"The peripheral nerve involvement in Parkinson disease: a multifaceted phenomenon","volume":"25","author":"Cossu","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2016.09.061_bb0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awg006","article-title":"Homocysteine and brain atrophy on MRI of non-demented elderly","volume":"126","author":"den Heijer","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.09.061_bb0050","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000000316","article-title":"Skin nerve \u03b1-synuclein deposits: a biomarker for idiopathic Parkinson disease","volume":"82","author":"Donadio","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.09.061_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","article-title":"Cutaneous neuropathy in Parkinson's disease: a window into brain pathology","volume":"128","author":"Doppler","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2016.09.061_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","article-title":"Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease","volume":"80","author":"Duan","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2016.09.061_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","article-title":"Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.09.061_bb0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mus.880130213","article-title":"The neurophysiological profile of vitamin B12 deficiency","volume":"13","author":"Fine","year":"1990","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2016.09.061_bb0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1529-8027.2012.00408.x","article-title":"Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects","volume":"17","author":"Gonz\u00e1lez","year":"2012","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jns.2016.09.061_bb0080","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","article-title":"Lewy body pathology involves cutaneous nerves","volume":"67","author":"Ikemura","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2016.09.061_bb0085","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.21600","article-title":"Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system","volume":"18","author":"Iranzo","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.09.061_bb0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00702-011-0689-3","article-title":"Malnutritional neuropathy under intestinal levodopa infusion","volume":"119","author":"Klostermann","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jns.2016.09.061_bb0095","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s004150050292","article-title":"Hyperhomocysteinaemia in Parkinson's disease","volume":"245","author":"Kuhn","year":"1998","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2016.09.061_bb0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1468-1331.2004.00973.x","article-title":"Hyperhomocysteinemia in l-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration","volume":"12","author":"Lamberti","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2016.09.061_bb0105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuro.2005.01.008","article-title":"Effects of homocysteine on the dopaminergic system and behavior in rodents","volume":"26","author":"Lee","year":"2005","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jns.2016.09.061_bb0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/gerona\/glr202","article-title":"Vitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs","volume":"67","author":"Leishear","year":"2012","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jns.2016.09.061_bb0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/hs0102.100483","article-title":"Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke","volume":"33","author":"Madonna","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2016.09.061_bb0120","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/mds.22807","article-title":"Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy","volume":"24","author":"Manca","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.09.061_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2013.09.007","article-title":"Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens","volume":"20","author":"Mancini","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2016.09.061_bb0130","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/01.STR.28.9.1739","article-title":"A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine and ischemic cerebrovascular disease","volume":"28","author":"Markus","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2016.09.061_bb0135","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.62.4.310","article-title":"Epidemiology of peripheral neuropathy","volume":"62","author":"Martyn","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2016.09.061_bb0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0022-510X(84)90147-3","article-title":"The peripheral neuropaty of vitamin B12 deficiciency","volume":"66","author":"McCombe","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2016.09.061_bb0145","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1212\/01.WNL.0000055899.24594.8E","article-title":"Effect of l-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status","volume":"60","author":"Miller","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.09.061_bb0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(03)00438-1","article-title":"Homocysteine and Alzheimer's disease","volume":"2","author":"Morris","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2016.09.061_bb0155","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/mds.22607","article-title":"Homocysteine levels after acute levodopa intake in patients with Parkinson's disease","volume":"24","author":"Mueller","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.09.061_bb0160","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archneur.61.5.657","article-title":"Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration","volume":"61","author":"Mueller","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2016.09.061_bb0165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(99)01660-8","article-title":"Nigral endotelial dysfunction, homocysteine and Parkinson's disease","volume":"354","author":"Mueller","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2016.09.061_bb0170","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00210-011-0629-7","article-title":"Inhibition of catechol-O-methyltransferase modifies acute homocysteine rise during repeated levodopa application in patients with Parkinson's disease","volume":"383","author":"Mueller","year":"2011","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.jns.2016.09.061_bb0175","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/brain\/awn102","article-title":"Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation","volume":"131","author":"Nolano","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jns.2016.09.061_bb0180","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/jnnp.57.12.1525","article-title":"Chronic idiopathic axonal polyneuropathy: a five year follow up","volume":"57","author":"Notermans","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2016.09.061_bb0185","series-title":"Cilinical Elektromyography. Nerve Conduction Studies","first-page":"98","article-title":"Uncommon nerve conduction studies","author":"Oh","year":"2003"},{"key":"10.1016\/j.jns.2016.09.061_bb0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF01616850","article-title":"Homocysteine, a risk factor for cardiovascular disease","volume":"8","author":"Prasad","year":"1999","journal-title":"Int. J. Angiol."},{"key":"10.1016\/j.jns.2016.09.061_bb0195","first-page":"273","article-title":"Vitamin B12 deficiency: a clinical and electrophysiological profile","volume":"45","author":"Puri","year":"2005","journal-title":"Electromyogr. Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2016.09.061_bb0200","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ajcn\/80.1.114","article-title":"Homocysteine, folate and vitamin B12 in mild cognitive impairment, Alzheimer's disease and vascular dementia","volume":"80","author":"Quadri","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jns.2016.09.061_bb0205","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","article-title":"Neuropathy in Parkinson disease: prevalence and determinants","volume":"77","author":"Rajabally","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2016.09.061_bb0210","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/ane.12011","article-title":"No association between neuropathy and restless legs in Parkinson's disease","volume":"127","author":"Rajabally","year":"2013","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2016.09.061_bb0215","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1523\/JNEUROSCI.14-07-04385.1994","article-title":"Macromolecular synhesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione","volume":"14","author":"Rantan","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jns.2016.09.061_bb0220","series-title":"R: a Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2013"},{"key":"10.1016\/j.jns.2016.09.061_bb0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.60.1.59","article-title":"Elevated plasma homocysteine levels in patients treated with levodopa","volume":"60","author":"Rogers","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2016.09.061_bb0230","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/archneur.59.10.1532","article-title":"Indications and usefulness of nerve biopsy","volume":"59","author":"Said","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2016.09.061_bb0235","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1001\/archneur.60.9.1296","article-title":"Challenges in the identification of cobalamin-deficiency polyneuropathy","volume":"60","author":"Saperstein","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2016.09.061_bb0240","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer's disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2016.09.061_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000338610","article-title":"The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors","volume":"12","author":"S\u0142awek","year":"2013","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.jns.2016.09.061_bb0250","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.HYP.0000127914.94292.76","article-title":"Homocysteine enhances endothelial apoptosis via upregulation of Fas-mediated pathways","volume":"43","author":"Suhara","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.jns.2016.09.061_bb0255","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-510X(02)00020-5","article-title":"Restless legs syndrome in Parkinson's disease","volume":"196","author":"Tan","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2016.09.061_bb0260","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.clinph.2005.04.003","article-title":"Patophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines","volume":"116","author":"Tankisi","year":"2005","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2016.09.061_bb0265","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.22021","article-title":"Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease","volume":"68","author":"Toth","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2016.09.061_bb0270","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/mds.22137","article-title":"Neuropathy as a potential complication of levodopa use in Parkinson's disease","volume":"23","author":"Toth","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.09.061_bb0275","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1600-0404.2003.00135.x","article-title":"Levodopa induced hyperhomocysteinaemia in Parkinson's disease","volume":"108","author":"Yasui","year":"2003","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2016.09.061_bb0280","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/mds.22511","article-title":"Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia","volume":"24","author":"Zoccolella","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2016.09.061_bb0285","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.2174\/092986710792232012","article-title":"Hyperhomocysteinemia in l-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?","volume":"17","author":"Zoccolella","year":"2010","journal-title":"Curr. Med. Chem."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16306281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X16306281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T20:24:04Z","timestamp":1718828644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X16306281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":57,"alternative-id":["S0022510X16306281"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2016.09.061","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyneuropathy in levodopa-treated Parkinson's patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2016.09.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}